Greenland Mines Ltd

GRML · NASDAQ · Basic Materials / Other Precious Metals & Mining

3.61USD-0.24 (-6.23%)

Price History

Full chart

Market Stats

Previous Close3.85

Open3.86

Day Range3.59 – 3.93

52-Week Range2.82 – 36.99

Volume444.96K

Market Cap113.40M

P/E (TTM)0.00

Forward P/E0.00

EPS-9.12

Dividend Yield0.00%

Beta2.48

50-Day Avg8.09

200-Day Avg15.17

About

Greenland Mines Ltd engages in the cell and gene therapy, and natural resources businesses. The company primarily explores palladium, gold, and platinum deposits. It focuses on the exploration and development of Skaergaard project located in Southeast Greenland and the Sarartoq neodymium-praseodymium (Nd-Pr) rare earths project in Southwest Greenland. The company is also involved in the development of KLTO-202, a gene therapy for the treatment and prevention of amyotrophic lateral sclerosis; and KLTO-101 for the treatment or prevention of Alzheimer's disease, as well as therapies to treat Parkinson's and other age-related disorders. The company was formerly known as Klotho Neurosciences, Inc. and changed its name to Greenland Mines Ltd in March 2026. Greenland Mines Ltd is based in Charlotte, North Carolina.

Company Details

SectorBasic Materials
IndustryOther Precious Metals & Mining
CEODr. Joseph A. Sinkule Pharm.D.
Employees5
Headquarters1300 South Boulevard, Charlotte, NC, United States, 28203, USA
Websitehttps://greenlandmines.com

Leadership

Dr. Joseph A. Sinkule Pharm.D.Founder, CEO, Chairman of the Board & Secretary · b. 1954
Mr. Jeffrey LeBlancChief Financial Officer · b. 1977
Dr. Shalom Z. Hirschman M.D.Medical Advisor & Director · b. 1936
Mr. Peter J. MoriartyChief Business Officer · b. 1950
Dr. Bo Moller StensgaardPresident · b. 1975
Dr. Miguel Chillon RodriguezChief Scientific Officer & Consultant · b. 1966
Dr. Gustavo L.A. Delendatti B.Sc (Hons), MAIG, Ph.D.Vice President of Exploration
Dr. Jakob Kløve KeidingChief Geologist

Financials

Income Statement

Currency: USD	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	-	-	-	0	0
Operating Income	-1.11M	-657.02K	-631.32K	-5.54M	-7.15M
EBITDA	-	-657.02K	-631.32K	-5.54M	-7.15M
Net Income	-1.11M	1.23M	-707.46K	-6.15M	-10.55M
R&D	-	-	-	0	634.19K
Interest Expense	-	-	76.21K	356.60K	2.31M

Balance Sheet

Currency: USD	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	-	118.25M	2.19M	2.46M	9.59M
Total Liabilities	-	4.93M	1.62M	1.27M	129.76K
Total Equity	-	113.32M	571.72K	1.19M	9.46M
Cash	-	340.96K	2.81K	63.74K	7.18M
Total Debt	-	-	1.47M	271.75K	-
Net Debt	-	-340.96K	1.46M	208.01K	-7.18M

Cash Flow

Currency: USD	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	-493.04K	-605.92K	-2.82M	-5.86M
Investing Cash Flow	-116.15M	23.85K	-123.50K	-
Financing Cash Flow	116.98M	509.00K	3.00M	12.97M
Capital Expenditure	3	4	123.50K	4
Free Cash Flow	-493.04K	-605.92K	-2.82M	-5.86M
FCF to OCF	100.00%	100.00%	100.00%	100.00%

Earnings

Report Date	Jun 30, 2022	Sep 30, 2022	Dec 31, 2022	Mar 31, 2023	Jun 30, 2023	Sep 30, 2023	Dec 31, 2023	Mar 31, 2024	Jun 30, 2024	Sep 30, 2024	Dec 31, 2024	May 15, 2025	Aug 18, 2025	Sep 30, 2025	Dec 31, 2025	Mar 31, 2026	Aug 17, 2026	Nov 12, 2026
EPS Estimate	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EPS Actual	-0.70	2.45	2.40	3.79	-0.87	1.65	0.86	-1.19	-1.44	-8.87	-3.82	-0.08	-0.12	-2.44	-0.92	-7.39	-0.03	-
Surprise	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Timing	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Key Statistics & Ratios

Market Cap113.40M

Enterprise Value26.52M

Trailing P/E0.00

Forward P/E0.00

Price / Sales0.00

Price / Book0.61

EPS-9.12

Book Value18.23

Revenue (TTM)0

Gross Profit (TTM)0

Profit Margin0.00%

Operating Margin0.00%

Return on Equity-63.50%

Return on Assets-30.77%

Shares Outstanding7.62M

Shares Float2.62M

Beta2.48

Dividend Yield0.00%

Dividend Rate0.00

Payout Ratio0.00%

Ownership Breakdown

Institutions: 7.20%
Insiders: 4.32%
Retail / Other: 88.48%

Top Fund Holders

Vanguard MStar Total Stk Mkt Idx Invest
1.55M0.64%
Vanguard Institutional Extnd Mkt Idx Tr
1.49M0.62%
Fidelity Extended Market Index
572.21K0.24%
Fidelity Series Total Market Index
159.20K0.07%
Fidelity Total Market Index
153.72K0.06%
Extended Equity Market Fund B
143.46K0.06%
Blackrock Extended Mkt Fund CF
143.46K0.06%
Extended Equity Market Fund E
143.46K0.06%
NT Ext Equity Mkt Index Fund - Lending
137.82K0.06%
Northern Trust Extended Eq Market Idx
137.82K0.06%
BlackRock Extended Equity Market Fund K
121.93K0.05%
NT Ext Equity Mkt Index Fund - NL
107.47K0.04%
Spartan Extended Market Index Pool F
83.62K0.03%
NT Ext Equity Mkt Idx Fd - DC - NL - T2
77.96K0.03%
Vanguard Instl Ttl Stck Mkt Index Trust
42.70K0.02%
Spartan Total Market Index Pool A1
40.98K0.02%
NT Ext Eq Mkt Idx Fd DC Lending Tier 5
29.93K0.01%
Fidelity Nasdaq Composite Index
17.48K0.01%
Extended Equity Market Fund M
14.66K0.01%
JHVIT Total Stock Market Index I
2.40K0.00%

Stock Splits

Aug 24, 20261:50